Muto T - Search Results

1

Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker.

Hosako M, Muto T, Nakamura Y, Tsuta K, Tochigi N, Tsuda H, Asamura H, Tomonaga T, Kawai A, Kondo T. Hosako M, et al. Among authors: muto t. J Proteomics. 2012 Jan 4;75(3):833-44. doi: 10.1016/j.jprot.2011.09.026. Epub 2011 Oct 5. J Proteomics. 2012. PMID: 22051404

2

Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis.

Muto T, Taniguchi H, Kushima R, Tsuda H, Yonemori H, Chen C, Sugihara Y, Sakamoto K, Kobori Y, Palmer H, Nakamura Y, Tomonaga T, Tanaka H, Mizushima H, Fujita S, Kondo T. Muto T, et al. J Proteomics. 2011 May 16;74(6):858-73. doi: 10.1016/j.jprot.2011.02.030. Epub 2011 Mar 6. J Proteomics. 2011. PMID: 21385629

3

Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression.

Matsui S, Ri C, Bolanos LC, Choi K, Shibamiya A, Ishii A, Takaishi K, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mimura N, Yoshimi A, Yokote K, Starczynowski DT, Sakaida E, Muto T. Matsui S, et al. Among authors: muto t. Leukemia. 2024 Apr 12. doi: 10.1038/s41375-024-02245-3. Online ahead of print. Leukemia. 2024. PMID: 38609495

4

A woman with schizophrenia who died due to Takotsubo cardiomyopathy occurring after electroconvulsive therapy.

Muto T, Kyono H. Muto T, et al. BMC Psychiatry. 2024 Feb 19;24(1):139. doi: 10.1186/s12888-024-05593-7. BMC Psychiatry. 2024. PMID: 38373994 Free PMC article.

5

Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study.

Muto T, Sakamoto M, Imaizumi S, Kamoi K. Muto T, et al. J Int Med Res. 2024 Jan;52(1):3000605231221081. doi: 10.1177/03000605231221081. J Int Med Res. 2024. PMID: 38170955 Free PMC article.

6

Three types of university students with subthreshold depression characterized by distinctive cognitive behavioral skills.

Shiraishi N, Sakata M, Toyomoto R, Yoshida K, Luo Y, Nakagami Y, Tajika A, Suga H, Ito H, Sumi M, Muto T, Ichikawa H, Ikegawa M, Watanabe T, Sahker E, Uwatoko T, Noma H, Horikoshi M, Iwami T, Furukawa TA. Shiraishi N, et al. Among authors: muto t. Cogn Behav Ther. 2024 Mar;53(2):207-219. doi: 10.1080/16506073.2023.2288557. Epub 2023 Nov 27. Cogn Behav Ther. 2024. PMID: 38008940

7

Possible association between vaccination against SARS-CoV-2 and recurrence of macular edema due to branch retinal vein occlusion: a case report.

Muto T, Machida S, Imaizumi S, Kamoi K. Muto T, et al. J Int Med Res. 2023 Nov;51(11):3000605231213777. doi: 10.1177/03000605231213777. J Int Med Res. 2023. PMID: 38000009 Free PMC article.

8

Effects of the novel selective κ-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors.

Ide S, Hirai T, Muto T, Yamakawa T, Ikeda K. Ide S, et al. Among authors: muto t. Sci Rep. 2023 Oct 24;13(1):18164. doi: 10.1038/s41598-023-45584-4. Sci Rep. 2023. PMID: 37875567 Free PMC article.

9

[Role of innate immune signaling and inflammation in the pathogenesis of myeloid malignancies].

Muto T. Muto T. Rinsho Ketsueki. 2023;64(9):962-969. doi: 10.11406/rinketsu.64.962. Rinsho Ketsueki. 2023. PMID: 37793872 Japanese.

10

Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy Participants.

Yamamiya I, Hunt A, Yamashita F, Sonnichsen D, Muto T, He Y, Benhadji KA. Yamamiya I, et al. Among authors: muto t. Clin Pharmacol Drug Dev. 2023 Sep;12(9):927-939. doi: 10.1002/cpdd.1271. Epub 2023 Jun 10. Clin Pharmacol Drug Dev. 2023. PMID: 37300358 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,256 results

Search Page